FP
ABMD

Financial Perspectives’s Abiomed Inc ABMD Stock Holding History

Financial Perspectives’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-5
Closed -$1.23K – 709
2022
Q3 		$1.23K Hold
5
– – ﹤0.01% 618
2022
Q2 		$1.24K Hold
5
– – ﹤0.01% 622
2022
Q1 		$1.66K Hold
5
– – ﹤0.01% 623
2021
Q4 		$1.8K Hold
5
– – ﹤0.01% 590
2021
Q3 		$1.63K Hold
5
– – ﹤0.01% 597
2021
Q2 		$1.56K Sell
5
-1,589
-100% -$487K ﹤0.01% 620
2021
Q1 		$5K Buy
1,594
+1,589
+31,780% +$509K ﹤0.01% 619
2020
Q4 		$1.62K Hold
5
– – ﹤0.01% 553
2020
Q3 		$1.39K Hold
5
– – ﹤0.01% 514
2020
Q2 		$1.21K Sell
5
-38
-88% -$7.63K ﹤0.01% 508
2020
Q1 		$6.24K Buy
43
+38
+760% +$6.31K 0.01% 366
2019
Q4 		$853 Buy
+5
New +$927 ﹤0.01% 485

Other funds holding ABMD

TRSOTSOK
Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
AW
Avion Wealth The Woodlands, Texas $484M AUM 15.17% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Financial Perspectives's ABMD Position: Q4 2022 in Review

Financial Perspectives sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 5 shares — an estimated $1.23K sold.

Financial Perspectives first reported a position in ABMD in Q4 2019 and held it in 12 quarters. The position peaked at $6.24K in Q1 2020. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Financial Perspectives reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Financial Perspectives sold 5 Abiomed Inc shares in Q4 2022, an estimated $1.23K.
  • Financial Perspectives first reported a position in Abiomed Inc in Q4 2019 and held it in 12 quarters.
  • Financial Perspectives's Abiomed Inc position peaked at $6.24K in Q1 2020.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Financial Perspectives's 13F filing for Q4 2022, filed 10 Jan 2024.